Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Current Leases (2019 - 2025)

Avanos Medical's Current Leases history spans 6 years, with the latest figure at $13.7 million for Q3 2024.

  • For Q3 2024, Current Leases rose 7.87% year-over-year to $13.7 million; the TTM value through Sep 2024 reached $13.7 million, up 7.87%, while the annual FY2023 figure was $12.8 million, 6.67% up from the prior year.
  • Current Leases for Q3 2024 was $13.7 million at Avanos Medical, down from $14.4 million in the prior quarter.
  • Across five years, Current Leases topped out at $15.6 million in Q3 2020 and bottomed at $11.5 million in Q1 2024.
  • The 5-year median for Current Leases is $14.3 million (2020), against an average of $13.9 million.
  • The largest annual shift saw Current Leases decreased 18.37% in 2022 before it increased 7.87% in 2024.
  • A 5-year view of Current Leases shows it stood at $15.5 million in 2020, then dropped by 5.16% to $14.7 million in 2021, then decreased by 18.37% to $12.0 million in 2022, then grew by 6.67% to $12.8 million in 2023, then increased by 7.03% to $13.7 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Current Leases are $13.7 million (Q3 2024), $14.4 million (Q2 2024), and $11.5 million (Q1 2024).